The total return over the past 12 months is -58.83% vs. +17.49% for the S&P 500. So far it's up -54.92% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (58.83%) | (7.64%) | (0.67%) | +6.22% | +13.77% | +4.90% |
| Total Return CAGR | (58.83%) | (7.64%) | (0.67%) | +6.22% | +13.77% | +4.90% |
| Revenue CAGR | +13.53% | +16.14% | +13.40% | +10.19% | +6.81% | +5.81% |
| Net Income CAGR | +46.56% | +59.00% | +47.58% | +28.57% | +12.93% | +9.33% |
| EPS CAGR | +45.99% | +63.44% | N/A | N/A | N/A | +4.85% |
| Free Cash Flow CAGR | +9.48% | +36.47% | +15.64% | +13.97% | +17.64% | +6.89% |
| Operating Cash Flow CAGR | +5.69% | +28.68% | +15.09% | +13.52% | +14.22% | +6.77% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Boston Scientific Corporation (BSX)
| Year | Start price | End price | BSX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $95.35 | $42.98 | (54.92%) | +11.72% | (66.64%) |
| 2025 | $89.32 | $95.35 | +6.75% | +17.72% | (10.97%) |
| 2024 | $57.81 | $89.32 | +54.51% | +24.89% | +29.62% |
| 2023 | $46.27 | $57.81 | +24.94% | +26.19% | (1.25%) |
| 2022 | $42.48 | $46.27 | +8.92% | (18.17%) | +27.09% |
| 2021 | $35.95 | $42.48 | +18.16% | +28.74% | (10.58%) |
| 2020 | $45.22 | $35.95 | (20.50%) | +18.37% | (38.87%) |
| 2019 | $35.34 | $45.22 | +27.96% | +31.22% | (3.26%) |
| 2018 | $24.79 | $35.34 | +42.56% | (4.56%) | +47.12% |
| 2017 | $21.63 | $24.79 | +14.61% | +21.70% | (7.09%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
